The influence of propranolol and dibenzyline on glycogenolytic effects of some biogenic amines in rat brain slices.
D000818:Animals; D001679:Biogenic Amines / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D001921:Brain / Q000378:metabolism; D001923:Brain Chemistry / Q000187:drug effects*; D002421:Caudate Nucleus / Q000032:analysis; D002540:Cerebral Cortex / Q000032:analysis; D000242:Cyclic AMP / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D018492:Dopamine Antagonists; D006003:Glycogen / Q000032:analysis* / Q000378:metabolism; D006632:Histamine / Q000494:pharmacology; D066298:In Vitro Techniques; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000494:pharmacology; D013788:Thalamus / Q000032:analysis
D001679:Biogenic Amines; D018492:Dopamine Antagonists; D010643:Phenoxybenzamine; D012701:Serotonin; D006632:Histamine; D006003:Glycogen; D011433:Propranolol; D000242:Cyclic AMP; D004298:Dopamine; D009638:Norepinephrine